Conversation with The Cancer Letter Orlando Health President Mark Roh: We Opted For a Florida-Centric Strategy January 10, 2014Vol.40 No.02By Paul Goldberg
Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida January 10, 2014Vol.40 No.02By Paul Goldberg
Free Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics January 03, 2014Vol.40 No.01
TCCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013Vol.36 No.12
TCCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013Vol.36 No.12
TCCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013Vol.36 No.12
